From integrated genomics to tumor lineage dependency

被引:20
作者
Garraway, LA
Sellers, WR
机构
[1] Dana Farber Canc Inst, Melanoma Program Med Oncol, Cambridge, MA USA
[2] Dana Farber Canc Inst, Dept Med Oncol, Cambridge, MA USA
[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Cambridge, MA 02138 USA
[4] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA
[5] MIT, Broad Inst, Cambridge, MA 02139 USA
关键词
D O I
10.1158/0008-5472.CAN-05-4604
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In principle, genomic information derived from tumors should illuminate critical cellular dependencies that are tractable to therapeutic targeting; however, realizing this ideal remains difficult. Using an integrated analysis of high-resolution single nucleotide polymorphism maps and gene expression databases associated with the NCI60 collection cancer cell lines, we identified the transcription factor MITF as an amplified oncogene in melanoma that is critical for anchoring lineage dependence and malignant character. Similar combined genomic approaches may be useful in other cancer types to learn how critical regulators of tumor lineage are linked to genomic alterations in cancer cells.
引用
收藏
页码:2506 / 2508
页数:3
相关论文
共 25 条
[1]  
AEZ JG, 2004, SCIENCE, V304, P1497
[2]   Hypoxia-inducible factor 1α is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells [J].
Buscà, R ;
Berra, E ;
Gaggioli, C ;
Khaled, M ;
Bille, K ;
Marchetti, B ;
Thyss, R ;
Fitsialos, G ;
Larribère, L ;
Bertolotto, C ;
Virolle, T ;
Barbry, P ;
Pouysségur, J ;
Ponzio, G ;
Ballotti, R .
JOURNAL OF CELL BIOLOGY, 2005, 170 (01) :49-59
[3]   THE MYC ONCOGENE - ITS ROLE IN TRANSFORMATION AND DIFFERENTIATION [J].
COLE, MD .
ANNUAL REVIEW OF GENETICS, 1986, 20 :361-384
[4]   Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation [J].
Davis, IJ ;
Hsi, BL ;
Arroyo, JD ;
Vargas, SO ;
Yeh, YA ;
Motyckova, G ;
Valencia, P ;
Perez-Atayde, AR ;
Argani, P ;
Ladanyi, M ;
Fletcher, JA ;
Fisher, DE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) :6051-6056
[5]   Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].
Demetri, GD ;
von Mehren, M ;
Blanke, CD ;
Van den Abbeele, AD ;
Eisenberg, B ;
Roberts, PJ ;
Heinrich, MC ;
Tuveson, DA ;
Singer, S ;
Janicek, M ;
Fletcher, JA ;
Silverman, SG ;
Silberman, SL ;
Capdeville, R ;
Kiese, B ;
Peng, B ;
Dimitrijevic, S ;
Druker, BJ ;
Corless, C ;
Fletcher, CDM ;
Joensuu, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480
[6]   Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].
Druker, BJ ;
Sawyers, CL ;
Kantarjian, H ;
Resta, DJ ;
Reese, SF ;
Ford, JM ;
Capdeville, R ;
Talpaz, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042
[7]   Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma [J].
Garraway, LA ;
Widlund, HR ;
Rubin, MA ;
Getz, G ;
Berger, AJ ;
Ramaswamy, S ;
Beroukhim, R ;
Milner, DA ;
Granter, SR ;
Du, JY ;
Lee, C ;
Wagner, SN ;
Li, C ;
Golub, TR ;
Rimm, DL ;
Meyerson, ML ;
Fisher, DE ;
Sellers, WR .
NATURE, 2005, 436 (7047) :117-122
[8]   Molecular biology of the androgen receptor [J].
Gelmann, EP .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (13) :3001-3015
[9]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[10]  
Kubo A, 1999, CLIN CANCER RES, V5, P4279